\-\ Texto\\:\\ \ \(0\)\
\-\ blood\\ pressure\\:\\ \\ 160\\/90\\.\ \(0\)\
\-\ av\\ graft\\ in\\ the\\ left\\ forearm\\ \\â\\€\\“\\ no\\ thrill\\ is\\ present\ \(0\)\
\-\ right\\-sided\\ surgical\\ scars\\ at\\ the\\ base\\ of\\ the\\ neck\\ and\\ on\\ the\\ anterior\\ chest\\ wall\\ from\\ previous\\ dialysis\\ catheters\ \(0\)\
\-\ elevated\\ serum\\ creatinine\ \(0\)\
\-\ angioplasty\\ and\\ subsequent\\ stent\\ placement\ \(0\)\
\-\ editor\\'s\\ note\\:\\ most\\ operators\\ would\\ not\\ place\\ a\\ stent\\ between\\ the\\ clavicle\\ and\\ the\\ first\\ rib\\ because\\ of\\ the\\ high\\ risk\\ of\\ stent\\ fragmentation\\ due\\ to\\ repetative\\ mechanical\\ stress\\ at\\ this\\ location\\ \\(this\\ same\\ rational\\ is\\ what\\ prohibits\\ most\\ operators\\ from\\ stenting\\ across\\ joints\\)\\ \\ angioplasty\\ alone\\,\\ followed\\ by\\ diligent\\ monitoring\\ of\\ dialysis\\ intrafistula\\ velocities\\ and\\ flow\\ rates\\ during\\ dialysis\\ and\\ repeat\\ angioplasty\\ when\\ necessary\\,\\ is\\ the\\ optimal\\ therapy\ \(0\)\
\-\ stenosis\\ in\\ the\\ left\\ subclavian\\ vein\\ at\\ the\\ level\\ of\\ the\\ thoracic\\ inlet\ \(0\)\
\-\ subclavian\\ vein\\ stenosis\ \(1\)\
\-\ intimal\\ hyperplasia\\ due\\ to\\ arterialization\\ of\\ flow\\ in\\ the\\ subclavian\\ vein\\,\\ leading\\ to\\ greater\\ vessel\\ caliber\\,\\ followed\\ by\\ repetitive\\ trauma\\ from\\ impingement\\ between\\ the\\ first\\ rib\\ and\\ clavicle\\.\\ \\ this\\ is\\ a\\ common\\ reason\\ for\\ dimished\\ flow\\ through\\ dialyis\\ fistulae\ \(0\)\
\-\ 47\\ year\\ old\\ female\\ with\\ end\\ stage\\ renal\\ disease\\ who\\ is\\ dialyzed\\ through\\ a\\ left\\ upper\\ extremity\\ arteriovenous\\ graft\\.\\ \\ the\\ flow\\ rates\\ in\\ the\\ graft\\ have\\ become\\ suboptimal\\.\ \(0\)\
\-\ most\\ operators\\ would\\ treat\\ this\\ lesion\\ with\\ angioplasty\\ alone\\ rather\\ than\\ with\\ stenting\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ operators\\:\\ 0\\.10177019264173434\ \(0\)\
\-\ angioplasty\\:\\ 0\\.1001518523066903\ \(0\)\
\-\ dialysis\\:\\ 0\\.07328469207077769\ \(0\)\
\-\ graft\\:\\ 0\\.06923723709962926\ \(0\)\
\-\ stent\\:\\ 0\\.06586555121553461\ \(0\)\
\-\ subclavian\\:\\ 0\\.0597420702426437\ \(0\)\
\-\ flow\\:\\ 0\\.05158089272800943\ \(0\)\
\-\ stenting\\:\\ 0\\.05075271128716909\ \(0\)\
\-\ clavicle\\:\\ 0\\.04728705264146221\ \(0\)\
\-\ rates\\:\\ 0\\.04534585225804968\ \(0\)\
\-\ vein\\:\\ 0\\.04235525098649475\ \(0\)\
\-\ alone\\:\\ 0\\.04224533042867646\ \(0\)\
\-\ repetative\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ prohibits\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ intrafistula\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ dimished\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ dialyis\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ dialyzed\\:\\ 0\\.04025350878523515\ \(0\)\
\-\ rib\\:\\ 0\\.03901574102005931\ \(0\)\
\-\ arterialization\\:\\ 0\\.03708845316623997\ \(0\)\
\-\ 160\\/90\\:\\ 0\\.035237014316430997\ \(0\)\
\-\ rational\\:\\ 0\\.035237014316430997\ \(0\)\
\-\ diligent\\:\\ 0\\.035237014316430997\ \(0\)\
\-\ thrill\\:\\ 0\\.03392339754724478\ \(0\)\
\-\ editor\\:\\ 0\\.03207195869743581\ \(0\)\
\-\ velocities\\:\\ 0\\.03207195869743581\ \(0\)\
\-\ fistulae\\:\\ 0\\.030758341928249597\ \(0\)\
\-\ stenosis\\:\\ 0\\.030570395276998782\ \(0\)\
\-\ suboptimal\\:\\ 0\\.029304215302137566\ \(0\)\
\-\ fragmentation\\:\\ 0\\.02820301869566776\ \(0\)\
\-\ optimal\\:\\ 0\\.02820301869566776\ \(0\)\
\-\ would\\:\\ 0\\.02777138701755333\ \(0\)\
\-\ catheters\\:\\ 0\\.027593286309254412\ \(0\)\
\-\ intimal\\:\\ 0\\.027593286309254412\ \(0\)\
\-\ inlet\\:\\ 0\\.02705546422863166\ \(0\)\
\-\ most\\:\\ 0\\.027025138927781862\ \(0\)\
\-\ first\\:\\ 0\\.026187063331377644\ \(0\)\
\-\ followed\\:\\ 0\\.026163249966929418\ \(0\)\
\-\ scars\\:\\ 0\\.02613915968314238\ \(0\)\
\-\ repetitive\\:\\ 0\\.025376355643584547\ \(0\)\
\-\ between\\:\\ 0\\.024735119052276197\ \(0\)\
\-\ av\\:\\ 0\\.024573201915439963\ \(0\)\
\-\ reason\\:\\ 0\\.024573201915439963\ \(0\)\
\-\ caliber\\:\\ 0\\.0229741040641472\ \(0\)\
\-\ forearm\\:\\ 0\\.02267292612902484\ \(0\)\
\-\ creatinine\\:\\ 0\\.02221130002458936\ \(0\)\
\-\ through\\:\\ 0\\.022163991035807018\ \(0\)\
\-\ impingement\\:\\ 0\\.02212432196536245\ \(0\)\
\-\ treat\\:\\ 0\\.022038969759827505\ \(0\)\
\-\ mechanical\\:\\ 0\\.0215578715148146\ \(0\)\
\-\ monitoring\\:\\ 0\\.0215578715148146\ \(0\)\
\-\ across\\:\\ 0\\.02085398713204173\ \(0\)\
\-\ due\\:\\ 0\\.02082444888541406\ \(0\)\
\-\ what\\:\\ 0\\.020600243519462685\ \(0\)\
\-\ 47\\:\\ 0\\.02047847070173592\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.02047847070173592\ \(0\)\
\-\ end\\:\\ 0\\.019809048445152015\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.01922533441999272\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.01904624440559418\ \(0\)\
\-\ place\\:\\ 0\\.018959266346367267\ \(0\)\
\-\ serum\\:\\ 0\\.018831828957704817\ \(0\)\
\-\ leading\\:\\ 0\\.018667263037690215\ \(0\)\
\-\ vessel\\:\\ 0\\.018587152034718026\ \(0\)\
\-\ become\\:\\ 0\\.018587152034718026\ \(0\)\
\-\ rather\\:\\ 0\\.018547617501644447\ \(0\)\
\-\ repeat\\:\\ 0\\.018354921819039985\ \(0\)\
\-\ joints\\:\\ 0\\.01785499381519666\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.017560297371646105\ \(0\)\
\-\ this\\:\\ 0\\.017555017594778684\ \(0\)\
\-\ from\\:\\ 0\\.017348434426770032\ \(0\)\
\-\ necessary\\:\\ 0\\.017283472614493436\ \(0\)\
\-\ stress\\:\\ 0\\.017107827496558294\ \(0\)\
\-\ stage\\:\\ 0\\.016643992826156834\ \(0\)\
\-\ same\\:\\ 0\\.016083167119826512\ \(0\)\
\-\ at\\:\\ 0\\.015859769216871683\ \(0\)\
\-\ placement\\:\\ 0\\.015837492663237578\ \(0\)\
\-\ pressure\\:\\ 0\\.015323894565398809\ \(0\)\
\-\ base\\:\\ 0\\.015285197638499391\ \(0\)\
\-\ subsequent\\:\\ 0\\.015189866200044802\ \(0\)\
\-\ previous\\:\\ 0\\.015152284012206831\ \(0\)\
\-\ note\\:\\ 0\\.01505965994293055\ \(0\)\
\-\ thoracic\\:\\ 0\\.01504135847536188\ \(0\)\
\-\ greater\\:\\ 0\\.014656239076121009\ \(0\)\
\-\ extremity\\:\\ 0\\.014270132281472317\ \(0\)\
\-\ risk\\:\\ 0\\.014133363686571171\ \(0\)\
\-\ because\\:\\ 0\\.013650768568886062\ \(0\)\
\-\ location\\:\\ 0\\.013610537383122798\ \(0\)\
\-\ elevated\\:\\ 0\\.013238887494790241\ \(0\)\
\-\ left\\:\\ 0\\.013097332455793352\ \(0\)\
\-\ by\\:\\ 0\\.012994254824154106\ \(0\)\
\-\ is\\:\\ 0\\.01283768900421748\ \(0\)\
\-\ during\\:\\ 0\\.011940681506501405\ \(0\)\
\-\ renal\\:\\ 0\\.011723632645927256\ \(0\)\
\-\ neck\\:\\ 0\\.011457731219262477\ \(0\)\
\-\ wall\\:\\ 0\\.01130209643944633\ \(0\)\
\-\ level\\:\\ 0\\.011246068619392383\ \(0\)\
\-\ when\\:\\ 0\\.011175028482264865\ \(0\)\
\-\ high\\:\\ 0\\.010678292516332491\ \(0\)\
\-\ trauma\\:\\ 0\\.010671272976063602\ \(0\)\
\-\ blood\\:\\ 0\\.010650278869905477\ \(0\)\
\-\ therapy\\:\\ 0\\.010432149754523347\ \(0\)\
\-\ \\:\\:\\ 0\\.010322144438270913\ \(0\)\
\-\ than\\:\\ 0\\.010223967374056045\ \(0\)\
\-\ common\\:\\ 0\\.010211265808020077\ \(0\)\
\-\ who\\:\\ 0\\.010173371731240648\ \(0\)\
\-\ anterior\\:\\ 0\\.010049282300286472\ \(0\)\
\-\ the\\:\\ 0\\.009469129089289438\ \(0\)\
\-\ upper\\:\\ 0\\.009415892718578622\ \(0\)\
\-\ chest\\:\\ 0\\.009336662100719264\ \(0\)\
\-\ present\\:\\ 0\\.008812825360418634\ \(0\)\
\-\ \\'s\\:\\ 0\\.00860295259528331\ \(0\)\
\-\ have\\:\\ 0\\.008449488942306354\ \(0\)\
\-\ surgical\\:\\ 0\\.008201925891559148\ \(0\)\
\-\ female\\:\\ 0\\.008021736399305176\ \(0\)\
\-\ lesion\\:\\ 0\\.007947740757992943\ \(0\)\
\-\ in\\:\\ 0\\.007696753061922464\ \(0\)\
\-\ disease\\:\\ 0\\.00637779699185253\ \(0\)\
\-\ to\\:\\ 0\\.005850248060862825\ \(0\)\
\-\ not\\:\\ 0\\.005638441423479156\ \(0\)\
\-\ a\\:\\ 0\\.005432873997515086\ \(0\)\
\-\ \\,\\:\\ 0\\.004944476082507532\ \(0\)\
\-\ and\\:\\ 0\\.004931753581704615\ \(0\)\
\-\ year\\:\\ 0\\.0043657774852644505\ \(0\)\
\-\ old\\:\\ 0\\.0039951351454897465\ \(0\)\
\-\ no\\:\\ 0\\.0039289687246748944\ \(0\)\
\-\ for\\:\\ 0\\.0033292609527064616\ \(0\)\
\-\ on\\:\\ 0\\.0033054384126275254\ \(0\)\
\-\ \\(\\:\\ 0\\.003298455370976532\ \(0\)\
\-\ \\)\\:\\ 0\\.0032581629776863245\ \(0\)\
\-\ of\\:\\ 0\\.003191884953369546\ \(0\)\
\-\ with\\:\\ 0\\.0016027969327382155\ \(0\)\
\-\ \\.\\:\\ 0\\.0008104916917202346\ \(0\)\
